| Identification | Back Directory | [Name]
Xenopsin-Related Peptide 2 (XP-2) | [CAS]
117442-29-2 | [Synonyms]
Xenopsin-Related Peptide 2 (XP-2)
L-Leucine, L-phenylalanyl-L-histidyl-L-prolyl-L-lysyl-L-arginyl-L-prolyl-L-tryptophyl-L-isoleucyl- | [Molecular Formula]
C60H88N16O10 | [MOL File]
117442-29-2.mol | [Molecular Weight]
1193.44 |
| Hazard Information | Back Directory | [Uses]
Xenopsin-Related Peptide 2 (XP-2) is an avian counterpart to amphibian Xenopsin (HY-P0253). Xenopsin-Related Peptide 2 displays abilities to release histamine from isolated rat mast cells and is as effective as synthetic Bradykinin.html" class="link-product" target="_blank">Bradykinin (HY-P0206)[1]. | [in vivo]
Xenopsin-Related Peptide 2 (XP-2) (0.3-3000 nM; intradermally; 50 μL) induces skin vascular permeability in rats[1]. | Animal Model: | Rats weighing 300-400 g[1] | | Dosage: | 0.3-3000 nM | | Administration: | Intradermal injection, 50 μL | | Result: | Increased skin vascular permeability in a dose-dependent manner. |
| [References]
[1] Carraway RE, et al. Xenopsin-related peptide generated in avian gastric extracts. Regul Pept. 1988 Sep;22(4):303-14. DOI:10.1016/0167-0115(88)90107-3 |
|
|